FKMCX | VEXAX | FKMCX / VEXAX | |
Total Expense Ratio | 0.71 | 0.05 | 1,420% |
Annual Report Gross Expense Ratio | 0.71 | 0.05 | 1,420% |
Fund Existence | 17 years | 25 years | - |
Gain YTD | 0.850 | 0.949 | 90% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 0 | 3000 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 6.99B | 108B | 6% |
Annual Yield % from dividends | 0.68 | 1.21 | 56% |
Returns for 1 year | 8.05 | 13.93 | 58% |
Returns for 3 years | 23.01 | 44.01 | 52% |
Returns for 5 years | 54.35 | 70.23 | 77% |
Returns for 10 years | 21.05 | 116.19 | 18% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
RWIEX | 70.65 | 0.39 | +0.56% |
American Funds Capital World Gr&Inc R4 | |||
MCYAX | 11.63 | 0.01 | +0.09% |
NYLI Candriam Emerging Markets Eq Cl A | |||
HDMBX | 14.39 | N/A | N/A |
Hartford Small Company HLS IB | |||
FPHAX | 24.61 | N/A | N/A |
Fidelity Select Pharmaceuticals Port | |||
HRSMX | 73.37 | N/A | N/A |
Hood River Small-Cap Growth Instl |